In our study, endothelial cells of the benign vascular tumor detected in the wolf were also CD44-negative, confirming a previous study on canine vascular tumors where all the hemangiomas investigated failed to express this marker, whilst more than half of the malignant vascular tumors investigated were immunoreactivity for this marker [4]. This evidence concerns the gene CD44 and cancer.